Management of MS in primary and secondary care NICE Clinical Guideline 186: an analysis of how it measures up
|
|
- Evangeline Shields
- 8 years ago
- Views:
Transcription
1 Management of MS in primary and secondary care NICE Clinical Guideline 186: an analysis of how it measures up 11 Introduction In October 2014, NICE (the National Institute for Health and Care Excellence) published the first revision of their Clinical Guideline for MS in England. The original Guideline (CG8) was published back in 2003 and, whilst flawed in places, it set out standards of care across the whole condition and across most therapeutic interventions, and so became a real standard of best practice. In the following article we look at what the 2014 Guideline recommends, how it differs from the 2003 Guideline and what the MS Trust perceives as the strengths and weaknesses of the new document. We also asked a variety of MS health professionals for their views on how the new Guideline measures up, which can be found in the second part of this article. What is a Clinical Guideline? According to NICE, they produce clinical guidelines that cover a range of topics, including: managing specific conditions improving health and managing medicines in different settings. Guideline recommendations set out: the care and services that are suitable for most people with a specific condition or need ways to promote and protect good health ways to prevent ill health. They promote integrated care where appropriate. NICE guidelines only cover health and care in England. Decisions on how they apply in other UK countries are made by Ministers in the Welsh Government, Scottish Government and Northern Ireland Executive. NICE Clinical Guidelines are available for everyone to use, however, it s generally anticipated that they will be of most value to GPs, and other non-specialist health professionals in clinical decision making. They can also be useful to NHS commissioners and managers to help plan services. NICE also produces an information for the public version of every guideline, which people with MS could use in consultations with their health professionals if they choose. What s in the 2014 Guideline? The 2014 NICE MS Guideline makes a series of recommendations about managing someone with MS in primary or secondary care, which can roughly be grouped into the following areas: Diagnosing MS including the importance of referring to a consultant neurologist if MS is suspected, common initial presentations, and excluding alternative diagnoses. It also recommends a review for someone with MS-type symptoms, but who does not achieve a diagnosis. Information and support particularly the importance of oral and written information at diagnosis. This recommendation includes, with the agreement of the person with MS, information for their family, carers and children. The Guideline also recommends a follow-up appointment with a healthcare professional with expertise in MS within 6 weeks of diagnosis, that everyone with MS should have an MS management plan (care plan); and covers advanced care planning and power of attorney where appropriate. Coordinating care covers management by the multidisciplinary team, described in the Guideline as: consultant neurologists MS nurses physiotherapists and occupational therapists speech and language therapists, psychologists, dietitians, social care and continence specialists GPs. That everyone with MS should have an appropriate named single point of contact to coordinate care and help them access services. There is also a recommendation around the clinician deciding how often the
2 12 person with MS should be seen based on their individual needs. Health promotion including smoking, exercise and flu vaccinations. Also assessment for risk of osteoporosis and pressure ulcers, and referral to palliative care services where applicable. The Guideline also looks at information for people with MS who are thinking about pregnancy. The Guideline does not recommend vitamin D solely for the purpose of treating MS. Symptom management although some non-pharmacological interventions are covered, the main focus is on the pharmacological management of symptoms. Recommendations are made around the following symptoms: fatigue mobility and balance fampridine (Fampyra) is not recommended on the basis that it is not cost effective spasticity nabiximols (Sativex) is not recommended on the basis that it is not cost effective oscillopsia emotional lability pain, including neuropathic and musculoskeletal cognitive problems. A tailored annual review for everyone with MS conducted by healthcare professionals with expertise in MS, to include MS symptoms, respiratory function, relapses, general health, comorbidities, social activity and participation, care and carers and an annual medication review. Relapse management should be offered within 14 days of a diagnosed relapse; first line treatment is oral methylprednisolone of 0.5g daily for 5 days; the potential side effects and complications of steroids should be discussed, as should inpatient admission followed by rehabilitation where appropriate, and the importance of informing the MS multidisciplinary team of the relapse. The Guideline also makes the following five recommendations for research, based on its review of the evidence, to improve NICE guidance and patient care in the future: Cognitive rehabilitation: What is the clinical and cost effectiveness of cognitive rehabilitation for people with MS? Continued relapses: Is IV methylprednisolone more clinically and cost effective than oral methylprednisolone in people with relapsing remitting MS and people with secondary progressive MS with continued relapses? Mobility: What is the optimal frequency, intensity and form of rehabilitation for mobility problems in people with MS? Spasticity: What non-pharmacological interventions are effective in reducing spasticity in people with MS? Vitamin D: Can vitamin D slow down the progression of disability in MS? How does the new Guideline differ from the 2003 Guideline? On a positive note, the 2014 Guideline recognises the impact of cognition as a symptom of MS and makes recommendations about this, which the 2003 Guideline did not. Overall, the greatest difference is that the 2003 Guideline offered recommendations about holistic management of MS with the exception of cognition from symptom onset to death. The 2014 Guideline does not. There are a number of reasons for this, but the primary one is that in the eleven years between MS Guidelines, NICE has issued symptomspecific guidance in some areas, such as neuropathic pain, the neurogenic bladder and bowel, and depression, consequently it does not include recommendations about these symptoms within the main MS Guideline. NICE has also restricted the evidence considered in the 2014 Guideline to trials conducted only in MS; the 2003 Guideline looked at evidence in other conditions for some symptoms such as spasticity, ataxia and mobility that might be common to more than one condition. Another drawback is the predominance given to randomised controlled trials (RCTs) when it came to the grading of evidence, which has resulted in specialist nurses, rehabilitation, physiotherapy, occupational therapy and speech and language therapy barely being covered by the Guideline. Consequently the 2014 Guideline is much more limited in scope than the original version. Comments from the MS Trust Although there are some positive points to be welcomed, such as the recommendations on the importance of providing clear and practical information for people with MS at the point of diagnosis and the emphasis on the vital role of the multidisciplinary team in the management of MS, overall the MS Trust is disappointed that the 2014 Guideline fails to deliver a comprehensive overview of what people with MS need and what the NHS should deliver. Whilst pleased to see the recommendation that people with MS should have a single point of contact and a comprehensive annual review with
3 a health professional with expertise in MS, we feel strongly that this was a missed opportunity to emphasise that MS specialist nurses are ideally placed to deliver this, due to their central role in the delivery of holistic care, which is a key indicator of overall service quality. The emphasis on the pharmacological management of symptoms in the Guideline means that the valuable role allied health professionals have in the management of symptoms including spasticity, fatigue and difficulties with speech or swallowing, is not truly recognised. Despite some positive recommendations, the Guideline fails to draw together these recommendations into a meaningful and comprehensive description of best practice in MS care. This was strongly present in the 2003 Guideline and its loss weakens the value and impact of the 2014 revision. 13 NICE Clinical Guideline The neurologist s thoughts David Rog, Consultant Neurologist, Greater Manchester Neurosciences Centre The NICE Guideline development process follows standardised procedures, including a scoping exercise to generate questions for which evidence is sought and assessed. If evidence is lacking for an intervention or service, recommendations cannot be made. A concern with any set of guidelines, though not legally mandated, is that they may be interpreted by commissioners as a lowest common denominator. If neurological rehabilitation services are configured to optimally manage patients with MS, a dynamic condition with physical, cognitive, psychological and sometimes psychiatric sequelae, affecting both the spinal cord with acute inflammatory relapses and longer-term neurodegenerative components, intuitively, such a framework could benefit in the optimal management of patients with many types of monophasic and/or limited neurological injuries. NICE Guideline 186 identifies fewer healthcare professionals involved in the coordination of care than the multidisciplinary team members recommended in the 2003 Clinical Guideline 8, which they purport to replace. For example, the role of rehabilitation consultants and ophthalmologists appears to have been omitted, except to recommend that the latter refer cases of optic neuritis to neurologists for further management! Provision of information and support for those newly diagnosed is welcome and this offers the opportunity to produce a standardised package, developed based upon the input and feedback of patients, supplemented with information on local services. The disparity between identification of symptoms in the comprehensive review and absence of recommendations for treatment, for example sexual dysfunction, is regrettable. The non-recommendation of nabiximols (Sativex) and fampridine (unless the patient is already receiving them) due to being not cost-effective, unfortunately leaves the minority of patients with intractable spasticity and gait impairment who note meaningful benefit from these products in limbo. The challenge to the MS community, prior to revision of these guidelines in 2016, is to generate further evidence, of sufficient quality for consideration under the NICE assessment criteria, to support optimal service provision for people with MS. NICE recommendations for research, especially cognitive rehabilitation are welcome but would be more meaningful if they mandated NHS funding bodies to prioritise grant proposals in these areas, effectively a funding call. The recommendation, to offer an appropriate single point of contact to coordinate care and help them access services undoubtedly challenges which healthcare professional is best placed to deliver this. At present this may vary across the country, but our service audit concluded that a third of patients hadn t visited their GP since diagnosis of MS and that the highest scores on the Friends and Family Test were achieved by the MS nurse. The comprehensive review guidelines, whilst welcome, intersperses both general health and MS-specific outcomes and will require novel ways to address these efficiently, perhaps through the use of questionnaires completed before the patient s appointment. Overall, whilst there are some useful new standards (diagnosis, information, comprehensive review), the terms of the NICE Guideline process coupled with incomplete evidence, means that a definitive service framework for optimal management of MS still eludes us.
4 14 NICE Clinical Guideline The MS nurse s perspective Rosie Grove, Clinical MS Specialist (Policy Development), UKMSSNA The UKMSSNA is disappointed that the NICE Guideline fails to reflect the unique contribution of the MS specialist nurse. We are pleased that provision of information has been highlighted and agree that equipping the patient with knowledge is vital, but this shouldn t be reduced to information giving. For example, there is no mention of the work usually undertaken by the specialist nurse in the early days. The growth in the number of disease modifying therapies now available means there is more to discuss and for patients to consider, so consultation appointments can be lengthy, but they are vital to help people be fully engaged in the process. Time spent listening and growing to understand the individual at this early point enables a bond of trust to develop that allows good communication to occur in the future. This is work best undertaken by an MS specialist nurse or clinician with the required specialist knowledge, but is not described in the guidance. MS nurses working in primary care are not delivering care prescribed by a neurologist, as is implied by the terminology of the Guideline. They are practitioners in their own right with a recognised specialist knowledge base and skill set. They provide accessible support for their patients and their primary care colleagues. For example, people living with MS attending their GP surgery are often told to Ask your MS nurse, in relation to a query. It would not be acceptable to use the term Consultant physician with expertise in MS care to replace the words Consultant neurologist in this document, as the term would not guarantee the level of education and competency required. For the same reason, we would have preferred the term specialist nurse or specialist therapist be used throughout the Guideline rather than clinician with expertise in MS. Expertise is too vague and open to misinterpretation. To paraphrase Donald Rumsfeld some people don t know what they don t know, so it s better to appoint people with the appropriate expertise in the first place and call them MS specialists. This lack of acknowledgement, combined with cost pressures on CCGs, leave MS specialist nurses in a vulnerable position. NICE Clinical Guideline - The neuropsychologist s view Dawn Langdon, Professor of Neuropsychology, Royal Holloway, University of London Cognitive symptoms are an important part of many people s experience of MS. What progress does the 2014 NICE Guideline for MS demonstrate for them? Both NICE Guidelines recommend access to a psychologist. The 2003 NICE Guideline says a clinical psychologist should be an integral member of the neurological rehabilitation team ( ). In the 2014 Guideline, this has been softened to involve a psychologist, although they still recommend that they should be a specialist with MS expertise (1.3.1). As part of Ongoing information and support, the 2014 NICE Guideline recommends that the possibility of cognitive problems should be broached with people with MS and their families (1.2.8). The 2014 NICE Guideline has a section on Cognition including memory ( ), which advises Consider referring people with persisting memory or cognitive problems to both an occupational therapist and a neuropsychologist to assess and manage the symptoms. I think this could have been better worded as Discuss a specialist referral for assessment and management of persistent cognitive problems with the person with MS and their family member/carer. The 2014 NICE Guideline recommends annual cognitive assessment, as part of the comprehensive review (1.6.3). Usefully, they also recommend advising that relapses can have a temporary effect on cognition (1.7.17). The 2003 NICE Guideline had quite detailed sections explaining that subtle MS cognitive impairment can interfere with communication and disease management, and that reduced independence and physical function not explicable by motor impairments is likely due to cognitive disability. These were useful pointers, but are not included in the 2014 NICE Guideline. Neither Guideline explains that self-report of cognitive function is influenced by depression, a key issue at consultation, especially for generalist primary care workers. And now for the good news: the clinical and cost effectiveness of cognitive rehabilitation for people with MS is the first of the 2014 NICE Guideline Research recommendations (2.1).
5 The MS Trust GEMSS Programme addressing the gaps in the NICE Guidance? Geraldine Mynors, GEMSS Programme Manager, MS Trust 15 Through the GEMSS programme (Generating Evidence in MS Services), the MS Trust is currently working with 11 teams of MS specialist nurses (including two multidisciplinary teams involving allied health professionals). This brings the number of teams supported to collect and analyse evaluation data about their services over the course of a year to 16. The 40 nurses involved in GEMSS have a combined caseload of over 17,500 people with MS a sizable proportion of the UK total and are spread across England and Scotland. The programme has identified the outcomes which MS specialist nurses (MSSNs) seek to achieve with their patients 1, developed measurement tools to track achievement of many of them, and to describe the services provided. A 30-question survey has been answered by over 1,200 people with MS under the care of GEMSS teams and has rated the extent to which they think MS specialist nurses have contributed to outcomes such as: remaining in employment feeling informed about MS prompt treatment for relapses obtaining benefits and other funding. A health professional stakeholder survey and case studies will provide further evidence of these benefits, and a new tool, the Dorset Specialist Neurological Intervention Audit Tool (SNIAT) is being used to track the different areas assessed during nurse consultations. Together with descriptive data about service Professional development caseloads and activity, and performance on Key Process Indicators such as the timeliness of annual reviews and holistic assessments for people newly diagnosed with MS, these sources will be used to create a rich picture of how MS specialist nurses operate and what they achieve. The final report is due for publication in the autumn of So, will the GEMSS MSSN project report address the evidence gaps exposed by the NICE Guideline development process? The project is a service evaluation, albeit on a large and comprehensive scale, rather than a clinical trial. The programme has not attempted to capture longitudinal data about individual patients over time a notoriously difficult thing to do even within a research study given the wide range of different outcomes targeted by MSSN services and against the backdrop of a degenerative condition like MS. Nevertheless, the GEMSS programme data will provide evidence that MS specialist nurses make a tangible difference to patients, will show the factors that make their services more or less efficient and effective, and demonstrate the complex and specialist range of skills that MSSNs bring to bear in their practice. The programme will therefore demonstrate conclusively that MSSNs are in a unique position to deliver the vital interventions particularly at new diagnosis, times of relapse and deterioration, and annual review which the NICE Guideline recommends. Reference: 1. Mynors G, Bowen A. MS specialist nursing in the UK 2014: the case for equitable provision. Letchworth: MS Trust; MS Study Day in Partnership with ACPIN Devon This study day will provide health and care professionals with an understanding of important issues relating to the care of people affected by MS. Date: Tuesday 24th February, 2015 Venue: The Watermark, Ivybridge, Devon Price: 50 +VAT for ACPIN members 65 +VAT for non-members Speakers include: Jenny Freeman, Reader in Physiotherapy and Rehabilitation, University of Plymouth Hilary Gunn, Lecturer in Physiotherapy, University of Plymouth Timothy Harrower, Consultant Neurologist, Royal Devon and Exeter Hospital Lou Jarrett, MS Clinical Nurse Specialist, Royal Devon and Exeter Hospital Dawn Langdon, Professor of Neuropsychology, Royal Holloway, University of London Jon Marsden, Professor of Neurorehabilitation, University of Plymouth.
Voting for your top research questions Survey
MS Priority Setting Partnership Voting for your top research questions Survey Prioritising important research questions for multiple sclerosis a partnership between people affected by MS and healthcare
More informationModelling sustainable caseloads for MS Specialist Nurses
Discussion Paper Briefing Report Consensus Modelling sustainable caseloads for MS Specialist Nurses November 2014 Report on a consensus process led by the MS Trust Authors: Geraldine Mynors*, Amy Bowen
More informationREHABILITATION MEDICINE by PROFESSOR ANTHONY WARD
REHABILITATION MEDICINE by PROFESSOR ANTHONY WARD What is Rehabilitation Medicine? Rehabilitation Medicine (RM) is the medical specialty with rehabilitation as its primary strategy. It provides services
More informationVictorian Nurse Practitioner Project Phase 4, Round 4.11 - Chronic Disease Management
Victorian Nurse Practitioner Project Phase 4, Round 4.11 - Chronic Disease Management Eastern Health Multiple Sclerosis Nurse Practitioner Service Model April 2014 Prepared by Jodi Haartsen and Deanna
More informationNeurorehabilitation Strategy Briefing Document and Position Paper
Neurorehabilitation Strategy Briefing Document and Position Paper Background What is neurorehabilitation? The World Health Organisation defines neurorehabilitation as: A problem-solving process in which
More informationEvidence for MS Specialist Services:
Discussion Paper Briefing Report Consensus Evidence for MS Specialist Services: Findings from the GEMSS MS specialist nurse project This is an executive summary. Read the full report and references at
More informationMellen Center for Multiple Sclerosis
Mellen Center Cleveland Clinic Marie Namey, RN, MSN, MSCN Mellen Center Cleveland Clinic Cleveland, OH Home of. Mellen Center for Multiple Sclerosis Mellen Center Mission The Mellen Center remains committed
More informationStroke rehabilitation
Costing report Stroke rehabilitation Published: June 2013 http://guidance.nice.org.uk/cg162 This costing report accompanies the clinical guideline: Stroke rehabilitation (available online at http://guidance.nice.org.uk/cg162).
More informationADULT HEALTH AND WELLBEING LONG-TERM NEUROLOGICAL CONDITIONS
ADULT HEALTH AND WELLBEING LONG-TERM NEUROLOGICAL CONDITIONS i. Summary The National Service Framework for long-term neurological conditions categorises neurological conditions as: Sudden-onset conditions
More informationRehabilitation Medicine Service for Adults with Physical Disabilities
Rehabilitation Medicine Service for Adults with Physical Disabilities Information for Professionals Rehabilitation Medicine Service Community & Therapy Services Group This leaflet has been designed to
More informationEvidence for MS Specialist Services:
Evidence for MS Specialist Services: Findings from the GEMSS MS specialist nurse evaluation project GGen Mul Geraldine Mynors Jane Suppiah Amy Bowen In this report Foreword 6 1. Introduction 7 1.1 Why
More informationNHS FORTH VALLEY Multiple Sclerosis Service Management of MS Relapses
NHS FORTH VALLEY Multiple Sclerosis Service Management of MS Relapses Approved 22/06/2010 Version Version 2 Date of First Issue 2002 Review Date 10/05/2016 Date of Issue 01/02/2010 EQIA Yes 22.06.10 Author
More informationRehabilitation Network Strategy 2014 2017. Final Version 30 th June 2014
Rehabilitation Network Strategy 2014 2017 Final Version 30 th June 2014 Contents Foreword 3 Introduction Our Strategy 4 Overview of the Cheshire and Merseyside Rehabilitation Network 6 Analysis of our
More information!!!!!!!!!!!! Liaison Psychiatry Services - Guidance
Liaison Psychiatry Services - Guidance 1st edition, February 2014 Title: Edition: 1st edition Date: February 2014 URL: Liaison Psychiatry Services - Guidance http://mentalhealthpartnerships.com/resource/liaison-psychiatry-servicesguidance/
More informationManaged Clinical Neuromuscular Networks
Managed Clinical Neuromuscular Networks Registered Charity No. 205395 and Scottish Registered Charity No. SC039445 The case for Managed Clinical Neuromuscular Networks 1. Executive summary Muscular Dystrophy
More informationHow To Manage A Hospital Emergency
ENHANCED SERVICE SPECIFICATION RISK PROFILING AND CARE MANAGEMENT SCHEME Introduction 1. This enhanced service has been designed by the NHS Commissioning Board (NHS CB) to reward GP practices 1 for the
More informationHealth Professionals who Support People Living with Dementia
Clinical Access and Redesign Unit Health Professionals who Support People Living with Dementia (in alphabetical order) Health Professional Description Role in care of people with dementia Dieticians and
More informationManifesto for Acquired Brain Injury Rehabilitation
Manifesto for Acquired Brain Injury Rehabilitation For further information please contact: Chloë Hayward UKABIF Executive Director PO Box 355 Plymouth PL3 4WD Tel: 01752 601318 Email: ukabif@btconnect.com
More informationSix Month Pilot Analysis: Improving Rehabilitation for Men with Prostate Cancer in North East London
Six Month Pilot Analysis: Improving Rehabilitation for Men with Prostate Cancer in North East London June 2015 Helen Whitney (Physiotherapist and Prostate Cancer Project Lead) Thufayel Islam (Prostate
More informationSECTION B THE SERVICES COMMUNITY STROKE REHABILITATION SPECIFICATION 20XX/YY
SECTION B THE SERVICES COMMUNITY STROKE REHABILITATION SPECIFICATION 20XX/YY SECTION B PART 1 - SERVICE SPECIFICATIONS Service specification number Service Commissioner Lead Provider Lead Period Date of
More informationImproving healthcare for people with long-term conditions
Improving healthcare for people with long-term conditions UWe-book: Number Two 1 Health and Well-being At UWE our research and development is real and dynamic, identifying problems and providing solutions
More informationUnderstanding Relapse in Multiple Sclerosis. A guide for people with MS and their families
Understanding Relapse in Multiple Sclerosis A guide for people with MS and their families Introduction You have been given this booklet because you have been diagnosed with Multiple Sclerosis (MS) and
More information1695 N.W. 9th Avenue, Suite 3302H Miami, FL. 33136. Days and Hours: Monday Friday 8:30a.m. 6:00p.m. (305) 355 9028 (JMH, Downtown)
UNIVERSITY OF MIAMI, LEONARD M. MILLER SCHOOL OF MEDICINE CLINICAL NEUROPSYCHOLOGY UHEALTH PSYCHIATRY AT MENTAL HEALTH HOSPITAL CENTER 1695 N.W. 9th Avenue, Suite 3302H Miami, FL. 33136 Days and Hours:
More informationTreating symptoms. An introduction to. Everyone diagnosed with MS can get treatment for their symptoms. The symptoms of MS. Who can get treatment?
Everyone diagnosed with MS can get treatment for their symptoms This resource is an introduction to the treatments that are available. The symbol will point you to further resources. An introduction to
More informationTime to Act Urgent Care and A&E: the patient perspective
Time to Act Urgent Care and A&E: the patient perspective May 2015 Executive Summary The NHS aims to put patients at the centre of everything that it does. Indeed, the NHS Constitution provides rights to
More informationA new value-based approach to the pricing of branded medicines. Submission from the MS Society March 2011
A new value-based approach to the pricing of branded medicines About multiple sclerosis Submission from the MS Society March 2011 Multiple sclerosis (MS) is one of the most common disabling neurological
More informationA patient and public guide to the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis
A patient and public guide to the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis 1st Annual Report 2015 (Data collection: 1 February 2014 30 April 2015) 2 Contents Background Who
More informationGuidance on competencies for management of Cancer Pain in adults
Guidance on competencies for management of Cancer Pain in adults Endorsed by: Contents Introduction A: Core competencies for practitioners in Pain Medicine B: Competencies for practitioners in Pain Medicine
More informationThe diagnosis of dementia for people living in care homes. Frequently Asked Questions by GPs
The diagnosis of dementia for people living in care homes Frequently Asked Questions by GPs A discussion document jointly prepared by Maggie Keeble, GP with special interest in palliative care and older
More informationRehabilitation. Care
Rehabilitation Care Bruyère Continuing Care is the champion of well-being for aging Canadians and those requiring Continuing Care, helping them to become and remain as healthy and independent as possible
More informationProfessional resources First edition June 2009. Translating the NICE and NSF guidance into practice A guide for occupational therapists
Professional resources First edition June 2009 Translating the and NSF guidance into practice A guide for occupational therapists 2 Foreword Multiple sclerosis (MS) is the most common disabling neurological
More informationNHS BOURNEMOUTH AND POOLE AND NHS DORSET
NHS BOURNEMOUTH AND POOLE AND NHS DORSET COMMISSIONING STATEMENT ON THE USE OF BETA-INTERFERON IN RELAPSING-REMITTING MULTIPLE SCLEROSIS OR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS, WHERE RELAPSES ARE
More informationGood end of life care in care homes
My Home Life Research Briefing No.6 This briefing sets out the key findings of a research review on good end of life care in care homes undertaken by Caroline Nicholson, in 2006, as part of the My Home
More informationOxford Centre for Enablement Continuing Disability Management Service Day Hospital Information
Oxford University Hospitals NHS Trust Oxford Centre for Enablement Continuing Disability Management Service Day Hospital Information Contents About the Oxford Centre for Enablement What does the service
More informationSkill Levels for Delivering High Quality Asthma and COPD Respiratory Care by Nurses in Primary Care
Skill Levels for Delivering High Quality Asthma and COPD Respiratory Care by Nurses in Primary Care September 2007 Revised December 2009, April 2014 Author: Ruth McArthur In conjunction with the PCRS-UK
More informationManaging MS, Managing spasticity: People with MS experiences of Sativex
Managing MS, Managing spasticity: People with MS experiences of Sativex Diane Redfern-Tofts Multiple Sclerosis Society October 2014 1 Contents Introduction... 3 Method... 3 Questionnaire design... 3 Respondents...
More informationParkinson s Disease: Factsheet
Parkinson s Disease: Factsheet Tower Hamlets Joint Strategic Needs Assessment 2010-2011 Executive Summary Parkinson s disease (PD) is a progressive neuro-degenerative condition that affects a person s
More informationGood Samaritan Inpatient Rehabilitation Program
Good Samaritan Inpatient Rehabilitation Program Living at your full potential. Welcome When people are sick or injured, our goal is their maximum recovery. We help people live to their full potential.
More informationCosting statement: Depression: the treatment and management of depression in adults. (update) and
Costing statement: Depression: the treatment and management of depression in adults (update) and Depression in adults with a chronic physical health problem: treatment and management Summary It has not
More informationNICE: REHABILITATION AFTER STROKE GUIDELINE. Sue Thelwell Stroke Services Co-ordinator UHCW NHS Trust
NICE: REHABILITATION AFTER STROKE GUIDELINE Sue Thelwell Stroke Services Co-ordinator UHCW NHS Trust Content About me! NICE Rehabilitation after Stroke to include background, remit and scope, guideline
More informationClinical Commissioning Policy: Disease Modifying Therapies For patients With Multiple Sclerosis (MS) December 2012. Reference : NHSCB/D4/c/1
Clinical Commissioning Policy: Disease Modifying Therapies For patients With Multiple Sclerosis (MS) December 2012 Reference : NHSCB/D4/c/1 NHS Commissioning Board Clinical Commissioning Policy: Disease
More informationLambeth and Southwark Action on Malnutrition Project (LAMP) Dr Liz Weekes Project Lead Guy s & St Thomas NHS Foundation Trust
Lambeth and Southwark Action on Malnutrition Project (LAMP) Dr Liz Weekes Project Lead Guy s & St Thomas NHS Foundation Trust Page 0 What is the problem? Page 1 3 million (5 % population) at risk of malnutrition
More informationSurvey of Nurses. End of life care
Survey of Nurses 28 End of life care HELPING THE NATION SPEND WISELY The National Audit Office scrutinises public spending on behalf of Parliament. The Comptroller and Auditor General, Tim Burr, is an
More informationRelapsing remitting MS
An introduction to Relapsing remitting MS What does it mean when you are diagnosed with relapsing remitting MS? There are three main types of MS: relapsing remitting MS, primary progressive MS and secondary
More informationObsessive-Compulsive Disorder and Body Dysmorphic Disorder
South West London and St George s Mental Health NHS Trust A National Service for Obsessive-Compulsive Disorder and Body Dysmorphic Disorder Springfield University Hospital A Referrer s Guide 1 Who we are
More informationHow To Cover Occupational Therapy
Guidelines for Medical Necessity Determination for Occupational Therapy These Guidelines for Medical Necessity Determination (Guidelines) identify the clinical information MassHealth needs to determine
More informationMultiple Sclerosis & MS Ireland Media Fact Sheet
Multiple Sclerosis & MS Ireland Media Fact Sheet This fact sheets gives a summary of the main facts and issues relating to Multiple Sclerosis and gives an overview of the services offered by MS Ireland.
More informationRehabilitation Services within Essex Cancer Network for people with Brain & CNS tumours
Rehabilitation Services within Essex Cancer Network for people with Brain & CNS tumours The NICE IOG for people with Brain & other CNS tumours (2006) states that patients with such tumours should have
More informationSouthwark Clinical Commissioning Group Lambeth Clinical Commissioning Group
Getting the Vision Right: A multi-disciplinary approach to providing integrated care for respiratory patients Dr Noel Baxter, GP NHS Southwark CCG Dr Irem Patel, Integrated Consultant Respiratory Physician
More informationRehabilitation and the role of carers
Rehabilitation and the role of carers Dr Jacinta Morgan Consultant in Rehabilitation Medicine National Clinical Lead, Rehabilitation Medicine Programme (HSE CSPD) EMSP Spring Conference Gibson Hotel Dublin,
More informationProfile: Kessler Patients
Profile: Kessler Patients 65 Breakthrough Years Kessler Institute has pioneered the course of medical rehabilitation since 1948. Today, as the nation s largest single rehabilitation hospital, we continue
More informationDepartment of Health/ Royal College of General Practitioners. Implementing a scheme for General Practitioners with Special Interests
Department of Health/ Royal College of General Practitioners Implementing a scheme for General Practitioners with Special Interests April 2002 Foreword Improved access and consistently high quality services
More informationThe national audit of services for people with multiple sclerosis 2011
The national audit of services for people with multiple sclerosis 2011 September 2011 Executive Summary Royal College of Physicians 2011 Executive Summary 1 Royal College of Physicians 2011. All rights
More informationMAPLES /PHOENIX REHABILITATION REFERRAL REFERRAL DETAILS:
MAPLES /PHOENIX REHABILITATION REFERRAL Each section must be completed by the treating health professional and goals for rehabilitation must be indicated. Once completed, please post the referral form
More informationRedford Court, Liverpool
Redford Court, Liverpool BIRT - the charity leading brain injury rehabilitation across the UK Registered Charity Nos. 800797-1 in England and Wales and SCO43579 in Scotland We aim to provide the best quality
More informationNICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.
bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published.
More informationBig Chat 4. Strategy into action. NHS Southport and Formby CCG
Big Chat 4 Strategy into action NHS Southport and Formby CCG Royal Clifton Hotel, Southport, 19 November 2014 Contents What is the Big Chat? 3 About Big Chat 4 4 How the event worked 4 Presentations 5
More informationIntravenous Methyl Prednisolone in Multiple Sclerosis
Intravenous Methyl Prednisolone in Multiple Sclerosis Exceptional healthcare, personally delivered Relapse management in multiple sclerosis Relapses in multiple sclerosis (MS) are common and caused by
More informationSSNAP s Acute Organisational Audit Report 2012: Performance Summary for South London
SSNAP s Acute Organisational Audit Report 2012: Performance Summary for South London The Sentinel Stroke National Audit Programme (SSNAP) s Acute Organisational Audit looks at how stroke services across
More informationPrivate treatment. Which treatments are available privately? Can I have private and NHS treatment together?
Stroke Helpline: 0303 3033 100 Website: stroke.org.uk Private treatment Because the NHS only offers limited access to some therapies after stroke, you might choose to explore the option of private treatment.
More informationHow To Become A Physio And Rehabilitation Medicine Specialist
EUROPEAN BOARD OF PHYSICAL AND REHABILITATION MEDICINE LOGBOOK EUROPEAN UNION OF MEDICAL SPECIALISTS UEMS IDENTIFICATION... 2 INSTRUCTIONS FOR USE... 3 THE TRAINING COURSE... 3 TRAINING PROGRAMME... 4
More informationREHABILITATION. begins right here
REHABILITATION begins right here Select Rehabilitation Hospital of Denton offers you a new direction in medical rehabilitation. Our 44-bed, state-of-the-science hospital offers unparalleled treatment to
More informationThe Regulation and Quality Improvement Authority. Review of Brain Injury Services in Northern Ireland
The Regulation and Quality Improvement Authority Review of Brain Injury Services in Northern Ireland September 2015 Assurance, Challenge and Improvement in Health and Social Care www.rqia.org.uk The Regulation
More informationIndependent Multidisciplinary Injury & Vocational Rehabilitation
Independent Multidisciplinary Injury & Vocational Rehabilitation Life Improving Solutions Life Improving Solutions About Us Medicess is a nationwide Injury & Vocational Rehabilitation Company. We help
More informationAdvanced Nurse Practitioner Adult Specialist Palliative Care
JOB DESCRIPTION ellenor Advanced Nurse Practitioner Adult Specialist Palliative Care Responsible to Accountable to: Head of Adult Community Services Director of Patient Care General ellenor is a specialist
More informationUnderstanding Relapse in Multiple Sclerosis
Understanding Relapse in Multiple Sclerosis A guide for people with MS and their families Introduction Relapses are very common in MS and largely unpredictable in terms of how often they occur, how severe
More informationProvincial Rehabilitation Unit. Patient Handbook
Provincial Rehabilitation Unit Patient Handbook ONE ISLAND FUTURE ONE ISLAND HEALTH SYSTEM Welcome to Unit 7, the Provincial Rehabilitation Unit. This specialized 20 bed unit is staffed by an interdisciplinary
More informationEarly Supported Discharge (in the context of Stroke Rehabilitation in the Community)
Early Supported Discharge (in the context of Stroke Rehabilitation in the Community) Gold Standard Framework This document was produced with reference to national standards for best practice (e.g. NICE
More informationSubstance misuse and behavioural addictions
Substance misuse and behavioural addictions Information about our services for primary healthcare professionals PROVIDING QUALITY INSPIRING INNOVATION DELIVERING VALUE Our substance misuse and behavioural
More informationResponse from Neurobehaviour Clinic at National Rehabilitation Hospital to Submission to Second Independent Monitoring Group: A Vision for Change
November 30 2009: Page 1 of 5 Response from Neurobehaviour Clinic at National Rehabilitation Hospital to Submission to Second Independent Monitoring Group: A Vision for Change Prepared by: Dr. Simone Carton,
More informationRehabilitation. Day Programs
Rehabilitation Day Programs Healthe Care is the hospital division of Healthe. As the largest privately owned network of private hospitals in Australia, we take pride in delivering premium care to our valued
More informationRehabilitation after critical illness
Quick reference guide Issue date: March 2009 Rehabilitation after critical illness NICE clinical guideline 83 Developed by the Centre for Clinical Practice at NICE Patient-centred care This is a quick
More informationCoventry and Warwickshire Repatriation Programme
NHS Arden Commissioning Support Unit Coventry and Warwickshire Repatriation Programme Large-scale service redesign and innovation to benefit patients Arden Commissioning Support Unit worked with Coventry
More informationSPECIFICATION FOR THE LOCAL COMMISSIONED SERVICE FOR THE MANAGEMENT ALCOHOL MISUSE
SPECIFICATION FOR THE LOCAL COMMISSIONED SERVICE FOR THE MANAGEMENT OF ALCOHOL MISUSE Date: March 2015 1 1. Introduction Alcohol misuse is a major public health problem in Camden with high rates of hospital
More informationUrology Nurse Practitioner Urology Research Nurse Australian Prostate Cancer Research Centre Epworth November 18, 2011
Urology Nurse Practitioner Helen Crowe Urology Nurse Practitioner Urology Research Nurse Australian Prostate Cancer Research Centre Epworth November 18, 2011 Nurse Practitioner Registered nurse who has
More informationLewy body dementia Referral for a Diagnosis
THE Lewy Body society The more people who know, the fewer people who suffer Lewy body dementia Referral for a Diagnosis Lewy Body Dementias REFERRAL FOR A DIAGNOSIS In the UK people with all forms of dementia
More informationNICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.
bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published.
More informationPatient s Handbook. Provincial Rehabilitation Unit ONE ISLAND HEALTH SYSTEM ONE ISLAND FUTURE 11HPE41-30364
Patient s Handbook Provincial Rehabilitation Unit ONE ISLAND FUTURE ONE ISLAND HEALTH SYSTEM 11HPE41-30364 REHABILITATION EQUIPMENT USED ON UNIT 7 During a patient s stay on Unit 7, various pieces of
More informationNCPC CANCER GROUP SUBMISSION TO THE PALLIATIVE CARE FUNDING REVIEW ON THE ROLE OF REHABILITATION IN PALLIATIVE CARE, MARCH 2011
NCPC CANCER GROUP SUBMISSION TO THE PALLIATIVE CARE FUNDING REVIEW ON THE ROLE OF REHABILITATION IN PALLIATIVE CARE, MARCH 2011 1. INTRODUCTION In October 2010, NCPC submitted an initial response to the
More informationQuality standard Published: 11 June 2015 nice.org.uk/guidance/qs89
Pressure ulcers Quality standard Published: 11 June 2015 nice.org.uk/guidance/qs89 NICE 2015. All rights reserved. Contents Introduction... 6 Why this quality standard is needed... 6 How this quality standard
More informationNational Institute for Health and Care Excellence. NICE Quality Standards Consultation Idiopathic Pulmonary Fibrosis
National Institute for Health and Care Excellence NICE Quality Standards Consultation Idiopathic Pulmonary Fibrosis Closing date: 5pm Tuesday 23 September 2014 Organisation Title Name Job title or role
More informationInspectorate of Mental Health Services. National Overview of Psychologists Working in Mental Health Services Ireland 2012
Inspectorate of Mental Health Services National Overview of Psychologists Working in Mental Health Services Ireland 2012 As part of the inspection of mental health services in 2012, the Inspector of Mental
More informationCheshire and Merseyside Rehabilitation Network Referral Criteria
Cheshire and Merseyside Rehabilitation Network Referral Criteria Date Approved: September 2014 Effective From: September 2014 Review Date: August 2015 1. Rehabilitation Definition Rehabilitation is an
More informationTHE ACQUIRED BRAIN INJURY STRATEGY FOR GRAMPIAN.
THE ACQUIRED BRAIN INJURY STRATEGY FOR GRAMPIAN. 2011-2016 * 1 January 2011. Contents 1. Executive Summary 2. Progress and Developments since Grampian BI Strategy 2004-2010 3. Definitions and Epidemiology
More informationInformation for Adults with Physical Disabilities and Long Term Neurological Conditions
Information for Adults with Physical Disabilities and Long Term Neurological Conditions Rehabilitation Medicine Service Community & Therapy Services Directorate of Operations This leaflet has been designed
More informationKeeping patients safe when they transfer between care providers getting the medicines right
PART 1 Keeping patients safe when they transfer between care providers getting the medicines right Good practice guidance for healthcare professions July 2011 Endorsed by: Foreword Taking a medicine is
More informationA systematic review of focused topics for the management of spinal cord injury and impairment
A systematic review of focused topics for the management of spinal cord injury and impairment icahe, University of South Australia For the NZ Spinal Cord Impairment Strategy Introduction This was the third
More informationIMPROVING YOUR EXPERIENCE
Comments trom the Aberdeen City Joint Futures Brain Injury Group The Aberdeen City Joint Futures Brain Injury Group is made up of representatives from health (acute services, rehabilitation and community),
More information31% of people experience pain at work at least once a week 1
Chartered Society of Physiotherapy Health and Social Care Bill Lords Report Stage briefing: Impact of NHS reforms on musculoskeletal physiotherapy February 2012 The Chartered Society of Physiotherapy (CSP)
More informationWHAT DOES THE PSYCHOLOGICAL THERAPIES HEAT TARGET MEAN TO YOU?
WHAT DOES THE PSYCHOLOGICAL THERAPIES HEAT TARGET MEAN TO YOU? NHS Boards are now half way through the first year of implementation of the HEAT target Deliver faster access to mental health services by
More informationRe: Provision of Neuro-Rehabilitation at the Royal National Hospital for Rheumatic Diseases OSC Briefing: For Information & Comment
Bath and North East Somerset (B&NES) Health and Social Services Overview & Scrutiny Panel Briefing FOR INFORMATION Potential Re-provision of RNHRD Neuro-Rehabilitation Service PART 1 Re: Provision of Neuro-Rehabilitation
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. National Early Warning Score (NEWS) Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust National Early Warning Score (NEWS) Policy Version.: 1.0 Effective From: 3 December 2014 Expiry Date: 3 December 2016 Date Ratified: 1 September 2014
More informationMaximising Quality in Residential Care Quality -improving NHS support for care home residents
My Home Life Conference RIBA, London June 22 nd 2012 Maximising Quality in Residential Care Quality -improving NHS support for care home residents Professor Finbarr Martin President, British Geriatrics
More informationAdvanced Nurse Practitioner Specialist. Palliative
JOB DESCRIPTION ellenor Advanced Nurse Practitioner Specialist Palliative Care Responsible to Accountable to: Head of Adult Community Services Director of Patient Care General ellenor is a specialist palliative
More informationBiogen Global Medical Grants Office Multiple Sclerosis: Areas of Interest
Biogen Global Medical Grants Office Multiple Sclerosis: Areas of Interest Cycle C June 2, 2015 1 Introduction The landscape for the treatment of relapsing Multiple Sclerosis (MS) has quickly evolved over
More informationExecutive Summary and Recommendations: National Audit of Learning Disabilities Feasibility Study
Executive Summary and Recommendations: National Audit of Learning Disabilities Feasibility Study Contents page Executive Summary 1 Rationale and potential impact of a future audit 2 Recommendations Standards
More informationMULTIPLE SCLEROSIS AUSTRALIA MULTIPLE SCLEROSIS RESEARCH AUSTRALIA
MULTIPLE SCLEROSIS AUSTRALIA MULTIPLE SCLEROSIS RESEARCH AUSTRALIA Submission to the ACT Legislative Assembly Health, Ageing, Community and Social Services Inquiry into the exposure draft of the Drugs
More informationSubmission by the Irish Pharmacy Union to the Department of Health on the Scope for Private Health Insurance to incorporate Additional Primary Care
Submission by the Irish Pharmacy Union to the Department of Health on the Scope for Private Health Insurance to incorporate Additional Primary Care Services January 2015 1 IPU Submission to the Department
More informationSexuality Issues in MS Nursing
Sexuality Issues in MS Nursing Dr. Edna Astbury-Ward, PhD, M.Sc. RGN, Dip. H.E, Cert Sexual & Relationship Therapy, Cert Counselling. Chronic diseases and degenerative conditions are often strongly linked
More informationNeurological Rehabilitation in Practice
Neurological Rehabilitation in Practice Christopher Ward Professor & Consultant in Rehabilitation Medicine University of Nottingham School of Community Health Sciences Derby Hospitals Foundation Trust
More information